Voloridge Investment Management, LLC Mersana Therapeutics, Inc. Transaction History

Voloridge Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$5.65 - $7.86 $24,001 - $33,389	-4,248 Reduced 5.35%	75,216 $440,000
Q3 2022 Nov 14, 2022	BUY	$4.63 - $8.0 $367,918 - $635,712	79,464 New	79,464 $537,000
Q1 2022 May 16, 2022	SELL	$3.74 - $6.63 $316,463 - $561,004	-84,616 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$5.48 - $9.86 $64,855 - $116,693	-11,835 Reduced 12.27%	84,616 $526,000
Q3 2021 Nov 15, 2021	BUY	$8.56 - $14.47 $825,620 - $1.4 Million	96,451 New	96,451 $910,000

121

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $198M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.